This study aimed to investigate the potential targets and pathways of the bioactive compounds of Viburnum opulus L. – a plant recognized in ethnopharmacology for its therapeutic applications in renal disorders - on glomerulonephritis (GN) disease. The phytochemical profile of V. opulus was obtained from review articles in the literature on plant contents. GN-associated target genes were retrieved from the GeneCards database, and interaction mapping was conducted using Cytoscape 3.10.0. The intersection of compound - target - disease was imported into the STRING database to create a PPI network. GO and KEGG enrichment analyses were applied to define the biological functions of the targets. A molecular docking study simulated the binding capabilities of key targets and active ingredients. A total of 9 bioactive constituents were identified from V. opulus, with rutin and quercetin demonstrating the highest binding affinities. The resulting compound–target interaction network consisted of 125 nodes and 358 edges. Central hub proteins within the PPI network included TP53, SRC, and EGFR indicating their potential role in the mechanism of action. GO and KEGG analyses suggested that the treatment of GN by V. opulus mainly involves the generation of cellular response to chemical and oxidative stress, protein tyrosine kinase activity, transcription regulatory complex, and other biological processes. The results of KEGG enrichment analysis indicate that V. opulus mainly involves some pathways, such as chemical carcinogenesis-receptor activation, EGFR tyrosine kinase inhibitor resistance in the treatment of GN. Molecular docking data presented that rutin and quercetin have the highest affinity score with TP53, SRC, and EGFR proteins. Overall, this study reveals the active compounds and potential molecular pathways of V. opulus in the treatment of GN and presents a source for further basic studies.
The pancreas stands out as a complicated organ vital for maintaining physiological balance with its exocrine and endocrine roles. It is aimed to present the genetic underpinnings of working basis of pancreas and its diseases with related biochemical pathways, especially with a focus on pancreatic cancers (PC). This article collects all current research and filters data about pancreatic biology and the molecular genetic backgrounds, and genomics pathways related pancreatic diseases. The pancreas has the highest number of different genetic disorders, which are always multifactorial. The pancreatic adenocarcinoma are particularly significant due to their rapid metastatic potential, extreme lethality, and surprising mortality rates. Various studies have revealed the different causes of the development of pancreatic cancers. And it is seen that it may be both a somatic and hereditary type of cancer. Some very important research has emphasised a substantial but insufficient network of gene-phenotype relationships for several mutations and susceptibility loci. This article collects the detailed perspective about existing literature to underline the molecular view of pancreatic cancers based on genetic, genomic and diagnostic principles. This article focus on isolated aspects such as genomics or diagnostics, this review provides an integrated perspective combining molecular genetics, genomic instability, and emerging diagnostic approaches. By synthesizing findings across multiple disciplines, this study highlights the importance of a systems-level understanding of pancreatic cancer and proposes a framework for future research directions.
Aging is a natural biological process that involves cellular senescence, tissue degradation, and organ function declines. Skin aging involves both intrinsic such as genetic predisposition and endocrine changes, and extrinsic factors such as solar radiation, environmental pollution, and stress factors. All these factors lead to skin aging through biochemical mechanisms and alterations in molecular pathways that include oxidative stress, mitochondria dysfunction, chronic inflammation, and hormonal alterations. Due to its historical context, anti-aging is an ever-trending research subject. Recent advances in molecular biology have further clarified the complex interactions between oxidative damage, signaling pathways, and extracellular matrix remodeling during the skin aging process. Here, mechanistic effects of antioxidant and hormone-based substances that can be used against skin aging were reviewed with particular foci were given to oxidative stress modulation, inflammatory regulation, and alterations on both collagen biosynthesis and cellular signaling. In addition, the safety profiles and potential risks associated with the long-term use of these agents are discussed based on current experimental and clinical evidence.